News | May 24, 2024
BaseLaunch announces a new partnership with AbbVie
Further strengthens BaseLaunch's global pharma industry partnerships
Further strengthens BaseLaunch's global pharma industry partnerships
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
Subscribe To Our Newsletter & Stay Updated
